Cynata Therapeutics Temettü
Temettü kriter kontrolleri 0/6
Cynata Therapeutics does not have a record of paying a dividend.
Anahtar bilgiler
n/a
Temettü verimi
-8.3%
Geri Alım Getirisi
Toplam Hissedar Getirisi | -8.3% |
Gelecekteki Temettü Verimi | n/a |
Temettü Büyümesi | n/a |
Bir sonraki temettü ödeme tarihi | n/a |
Eski temettü tarihi | n/a |
Hisse başına temettü | n/a |
Ödeme oranı | n/a |
Son temettü güncellemeleri
Güncelleme yok
Recent updates
Here's Why We're Watching Cynata Therapeutics' (ASX:CYP) Cash Burn Situation
Sep 21Will Cynata Therapeutics (ASX:CYP) Spend Its Cash Wisely?
May 29We're A Little Worried About Cynata Therapeutics' (ASX:CYP) Cash Burn Rate
Feb 09We're Interested To See How Cynata Therapeutics (ASX:CYP) Uses Its Cash Hoard To Grow
Feb 02We Think Cynata Therapeutics (ASX:CYP) Can Easily Afford To Drive Business Growth
Sep 09Here's Why We're Not At All Concerned With Cynata Therapeutics' (ASX:CYP) Cash Burn Situation
May 26Here's Why We're Not Too Worried About Cynata Therapeutics' (ASX:CYP) Cash Burn Situation
Dec 31We're Not Worried About Cynata Therapeutics' (ASX:CYP) Cash Burn
Aug 11Ödemelerde İstikrar ve Büyüme
Temettü verilerini getirme
İstikrarlı Temettü: Insufficient data to determine if CYP's dividends per share have been stable in the past.
Büyüyen Temettü: Insufficient data to determine if CYP's dividend payments have been increasing.
Piyasaya Karşı Temettü Getirisi
Cynata Therapeutics Piyasaya Karşı Temettü Getirisi |
---|
Segment | Temettü Verimi |
---|---|
Şirket (CYP) | n/a |
Pazarın Alt %25'i (AU) | 2.6% |
Pazarın En İyi %25'i (AU) | 6.1% |
Sektör Ortalaması (Biotechs) | 2.2% |
Analist tahmini (CYP) (3 yıla kadar) | n/a |
Önemli Temettü: Unable to evaluate CYP's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
Yüksek Temettü: Unable to evaluate CYP's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Hissedarlara Ödenen Kazanç
Kazanç Kapsamı: Insufficient data to calculate CYP's payout ratio to determine if its dividend payments are covered by earnings.
Hissedarlara Nakit Ödeme
Nakit Akışı Kapsamı: Unable to calculate sustainability of dividends as CYP has not reported any payouts.